Skip to main content

Blood Test May Provide New Option for Colorectal Cancer Screening

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 3, 2025.

via HealthDay

MONDAY, Feb. 3, 2025 -- A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S. population, according to a study presented at the American Society of Clinical Oncology annual Gastrointestinal Cancers Symposium, held from Jan. 23 to 25 in San Francisco.

Aasma Shaukat, M.D., from the New York University Grossman School of Medicine in New York City, and colleagues previously evaluated clinical performance of an investigational blood-based screening test for detecting molecular signals of advanced colorectal neoplasia (ACN) in an average-risk population. This analysis evaluated how the test would perform in the standard U.S. population, weighting the validation cohort (27,010 participants aged 45 to 85 years) to the U.S. Census sex and age distribution.

The researchers report that after performance was weighted to match U.S. Census sex and age distributions, sensitivity for CRC was 81.1 percent, specificity for those without ACN was 90.4 percent, negative predictive value for those without ACN was 90.5 percent, and positive predictive value for ACN was 15.5 percent. For advanced precancerous lesions, sensitivity was 13.7 percent.

"Additional colorectal cancer screening tests that are convenient, safe, and easy to complete are needed," Shaukat said in a statement. "Until now, we have only had stool-based tests and colonoscopy or sigmoidoscopy. A blood test has the potential for improving colorectal cancer screening rates."

Several authors disclosed financial ties to Freenome.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

2011 to 2023 Saw Increase in Prevalence of Obesity Among Children

WEDNESDAY, July 2, 2025 -- The prevalence of obesity increased among children and adolescents from 2011 to 2023, with the increase most pronounced among Black youths, according to...

2023 to 2024 COVID-19 Vaccine Provided Additional Effectiveness

WEDNESDAY, July 2, 2025 -- The 2023 to 2024 COVID-19 vaccine provided additional effectiveness against medically attended COVID-19, according to a study published online June 24...

Men With Hidradenitis Suppurativa Perceive Better Physician Communication

WEDNESDAY, July 2, 2025 -- Male patients with hidradenitis suppurativa (HS) perceive better physician communication with respect to demonstrating respect, listening, and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.